Literature DB >> 24668935

Hepatic venous congestion in living donor grafts in liver transplantation: is there an effect on hepatocellular carcinoma recurrence?

Suk-Won Suh1, Jeong-Moo Lee, Tae You, Young Rok Choi, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh.   

Abstract

A certain degree of graft congestion in living donor liver transplantation (LDLT) using a right liver graft may be inevitable because of the mismatch between the inflow and outflow structures of the liver. The subsequent inflammatory reaction and rapid regeneration of the graft have been suggested as causes of tumor recurrence. Therefore, we investigated the influence of graft congestion on hepatocellular carcinoma (HCC) recurrence after LDLT. Two hundred eighty-nine LDLT patients for HCC within the University of California San Francisco criteria between November 1999 and February 2012 were investigated. Patients were assigned to groups on the basis of the degree of congestion (≤10% for group A and >10% for group B), which was determined by 3-dimensional reconstruction of posttransplant multidetector helical computed tomography within 2 weeks. Perioperative characteristics, regeneration rates after 6 months, and recurrence rates were compared between the groups, and a multivariate analysis of the influence of congestion on tumor recurrence was subsequently completed. No significant difference in demographics was found. Group B had more elevated peak posttransplant levels of aspartate aminotransferase (296.26 versus 227.53, P = 0.05), alanine aminotransferase (382.91 versus 276.98, P = 0.04), and highly selective C-reactive protein (5.41 versus 3.55, P < 0.001); a higher noncongestive section regeneration rate (25.8% versus 13.6%, P = 0.012); and a higher recurrence rate (30.4% versus 9.7%, P = 0.01) than group A. Graft congestion > 10% [hazard ratio (HR) = 3.10, 95% confidence interval (CI) = 1.15-8.35, P = 0.03], microvascular invasion (HR = 5.43, 95% CI = 2.04-14.44, P < 0.01), and an alpha-fetoprotein level > 200 IU/L (HR = 2.98, 95% CI = 1.10-8.03, P = 0.03) were significantly related to tumor recurrence. Liver congestion may promote the recurrence of HCC after LDLT; therefore, it should be minimized.
© 2014 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24668935     DOI: 10.1002/lt.23877

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  6 in total

1.  Value of Two-Dimensional Shear Wave Elastography for Assessing Acute Liver Congestion in a Bama Mini-Pig Model.

Authors:  Li-Ting Xie; Dan-Xia Xu; Guo Tian; Li-Yun Zhong; Qi-Yu Zhao; Qing-Hong Ke; Tian-An Jiang
Journal:  Dig Dis Sci       Date:  2018-05-08       Impact factor: 3.199

2.  Serum alanine aminotransferase to hemoglobin ratio and radiological features predict the prognosis of postoperative adjuvant TACE in patients with hepatocellular carcinoma.

Authors:  Zicong Xia; Yulou Zhao; Hui Zhao; Jing Zhang; Cheng Liu; Wenwu Lu; Lele Wang; Kang Chen; Junkai Yang; Jiahong Zhu; Wenjing Zhao; Aiguo Shen
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738

3.  Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital.

Authors:  Junichi Togashi; Nobuhisa Akamastu; Norihiro Kokudo
Journal:  Hepatobiliary Surg Nutr       Date:  2016-10       Impact factor: 7.293

4.  Alanine aminotransferase to hemoglobin ratio is an indicator for disease progression for hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization.

Authors:  Zhi-Huan Lin; Xing Li; Ying-Fen Hong; Xiao-Kun Ma; Dong-Hao Wu; MingSheng Huang; Zhan-Hong Chen; Jie Chen; Min Dong; Li Wei; Tian-Tian Wang; Dan-Yun Ruan; Ze-Xiao Lin; Xiang Zhong; Yan-Fang Xing; Jing-Yun Wen; Xiang-Yuan Wu; Qu Lin
Journal:  Tumour Biol       Date:  2015-09-28

5.  Tumour site is a risk factor for hepatocellular carcinoma after hepatectomy: a 1:2 propensity score matching analysis.

Authors:  Lian Li; Liangliang Xu; Siqi Zhou; Peng Wang; Ming Zhang; Bo Li
Journal:  BMC Surg       Date:  2022-03-21       Impact factor: 2.102

6.  Successful use of venous graft from native liver with hepatocellular carcinoma during living donor liver transplantation with no impact on recurrence rate: A retrospective cohort study.

Authors:  Hazem Mohamed Zakaria; Emad Hamdy Gad; Nahal Kamel Gaballa; Ahmed Nabil Sallam; Islam Ismail Ayoub; Mohamed Eltabbakh; Shimaa Saad Elkholy; Sameh Abokoura; Taha Yassein; Osama Hegazy; Hany Abdelmeguid Shoreem; Hossam Eldeen Mohamed Soliman; Amr Ahmed Aziz; Mohammad Taha
Journal:  Ann Med Surg (Lond)       Date:  2022-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.